Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.

"for the toronto cohort dna methylation idat files have been deposited to the gene expression omnibus (geo; gse180061). supplementary table 1) [ ]. data processing was conducted as previously published [ ]. briefly raw data"

"Declarations Conflict of interestNone of the authors have any relevant financial or non-financial interests to disclose. Ethical approvalEthics approval for this study was provided by the University Health Network, Toronto, ON, Canada (CAPCR 18-5820). Conflict of interest None of the authors have any relevant financial or non-financial interests to disclose."

"Funding Justin Z. Wang was funded by the Vanier Scholarship from the Canadian Institutes for Health Research and the Neurosurgery Research Educational Fund & Southeastern Brain Tumor Foundation Research Fellowship and American Association of Neurological Surgeons."